Insmed (INSM) Change in Inventory (2018 - 2026)
Insmed (INSM) posted quarterly Change in Inventory of $1.9 million for Q1 2026, up 84.72% year-over-year from $1.0 million in Q1 2025, and down 83.97% quarter-over-quarter from $11.8 million in Q4 2025.
Analysis
Insmed (INSM) Change in Inventory (2018 - 2026) Analysis & Trends
Insmed's Change in Inventory history runs 9 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 84.72% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $32.4 million (up 85.4% YoY), while the FY2025 annual figure was $31.5 million, up 84.93% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.9 million, down from $11.8 million in the prior quarter.
- The five-year high for Change in Inventory was $13.8 million in Q3 2025, with the low at -$2.2 million in Q1 2022.
- The 5-year median for Change in Inventory is $2.1 million (2024), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory slumped 181.34% in 2022, then soared 998.0% in 2023.
- Insmed's Change in Inventory stood at $2.3 million in 2022, then jumped by 89.65% to $4.4 million in 2023, then slumped by 52.14% to $2.1 million in 2024, then surged by 454.38% to $11.8 million in 2025, then slumped by 83.97% to $1.9 million in 2026.
- Business Quant data shows INSM's Change in Inventory at $1.9 million in Q1 2026, $11.8 million in Q4 2025, and $13.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 11.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.97 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | 13.76 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Mar 31, 2024 | 598,000.00 |
| Dec 31, 2023 | 4.43 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 6.89 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 2.34 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | -2.24 Mn |
| Dec 31, 2021 | -1.13 Mn |
| Sep 30, 2021 | 7.03 Mn |